人工智能用于预测自身免疫性风湿性疾病的治疗反应:进展,挑战和未来的前景
Yanli Yang1, Yang Liu1, Yu Chen2
1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Frontiers in immunology
|November 6, 2024
概括
人工智能 (AI) 提供了预测自身免疫性类风湿性疾病 (ARD) 治疗反应的新方法. 这可能会导致个性化医疗,并为患有这些复杂疾病的患者提供更好的治疗结果.
科学领域:
- 类风湿病学 类风湿病学
- 医疗人工智能 医疗人工智能
- 精准医学是一门精准的医学.
背景情况:
- 自身免疫性类风湿性疾病 (ARD) 是一个日益严重的全球健康问题,其流行率越来越高.
- 这些异质性疾病表现出复杂的病理生理学,导致治疗疗效变化,需要个性化策略.
- 目前在ARD中的经验性治疗选择往往导致延迟,不可逆转的器官损伤和降低患者的生活质量.
研究的目的:
- 批判性地审查人工智能 (AI) 的进展,以预测ARD的治疗反应.
- 突出目前在风湿病学中最先进的AI应用.
- 确定挑战,并提出未来的研究方向,用于ARD治疗中的AI.
主要方法:
- 关于人工智能在风湿病学中的应用的最新文献的综述.
- 对人工智能在疾病诊断,风险分层,预后评估和对ARD治疗反应预测中的作用的分析.
- 对当前人工智能方法及其对临床实践的影响进行批判性评估.
主要成果:
- 人工智能正在成为类风湿病学的转型工具,提供新的见解和方法.
- 人工智能在提高疾病诊断,风险分层和ARD的预后评估方面显示出潜力.
- 人工智能驱动的治疗反应预测有望为更精确和更有针对性的治疗策略提供希望.
结论:
- 人工智能的进步为在ARD中开发个性化和有效的干预提供了巨大的潜力.
- 需要进一步的研究来克服挑战,并充分利用AI在风湿病学方面的能力.
- 在临床实践中实施人工智能可以改善患者护理和ARD患者的治疗结果.
相关概念视频
Autoimmune Disorders
390
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
390
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
Inflammatory Bowel Disease IV: Pharmacological Management
116
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
116


